Experimental Gerontology

GLP-1 receptor agonists, epigenetic aging, and the prospect of pharmacological healthspan extension

By Dana Al-Ali, Nady El Hajj

Figure 1 from Experimental Gerontology — Figure 1. Al-Ali et al.

ReviewInterventions

The paper

Dana Al-Ali, Nady El Hajj

Sidra Medical and Research Center; Hamad bin Khalifa University

Experimental Gerontology, 14 Sep 2026

doi.org/10.1016/j.exger.2026.113325 PubMed 42735804

Nature Medicine4 Oct 2026
Semaglutide may protect kidneys by reducing vascular resistance
Neurology Genetics4 Oct 2026
GLP-1 receptor agonists link to lower stroke and Alzheimer risk
GeroScience3 Oct 2026
Diet benefits for epigenetic aging may reflect familial factors
Diabetes, Obesity & Metabolism8 Oct 2026
Diabetes drug class linked to slightly less frailty progression